Riskpilot← Back to searchSign inGet full accessAplagon Oy
OYActiveY-tunnus 2251305-0Tukholmankatu 8-AResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20093 employeeswww.aplagon.com
Revenue 2024
EUR 0
EBITDA margin
—
0% vs 2023
Equity ratio
-880.2%
Financial strength
Net profit 2024
EUR -950K
+4% vs 2023
| Revenue | EUR 0 | — |
| EBITDA | EUR -738K | +0% |
| Net profit | EUR -950K | +4% |
| Total assets | EUR 399K | -48% |
| Equity | EUR -3,5M | -37% |
| Employees | 3 | — |
Legal name
Aplagon Oy
Y-tunnus number
2251305-0
Legal form
Osakeyhtiö
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
11. helmikuuta 2009
Share capital
EUR 2 500
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on biotekniikka-, lääketeollisuus- ja laboratoriotuotteiden ja -laitteiden kehitys, valmistus ja myynti, diagnostiikka, lääkintäpalveluiden tuottaminen ja siihen liittyvät konsultointi-, tutkimus- ja koulutuspalvelut. Yhtiö voi toimintaansa varten ostaa ja myydä sekä vuokrata ja antaa vuokralle kiinteää omaisuutta sekä omistaa, myydä ja hallita osakkeita ja muita arvopapereita kuitenkaan ammattimaista arvopaperikauppaa tai sijoitustoimintaa harjoittamatta.
Address
Tukholmankatu 8-A
Phone
+3580407625159
Email
aki.prihti@aplagon.com
Website
www.aplagon.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 1 151 | 0 |
| Staff expenses | −157 | −130 | −139 | −167 | −264 | −465 | −449 |
| EBITDA | −806 | −806 | −658 | −789 | −745 | −741 | −738 |
| Depreciation & amort. | −260 | −364 | −371 | −310 | −260 | −216 | −134 |
| EBIT | −1 066 | −1 170 | −1 029 | −1 099 | −1 005 | −957 | −872 |
| Net financials | −27 | −37 | −28 | −35 | −35 | −35 | −79 |
| Profit before tax | −1 093 | −1 206 | −1 056 | −1 134 | −1 040 | −992 | −950 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −1 093 | −1 206 | −1 056 | −1 134 | −1 040 | −992 | −950 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 2 055 | 2 352 | 1 254 | 2 278 | 2 246 | 771 | 399 |
| Equity | −460 | −566 | −1 623 | −529 | −1 569 | −2 561 | −3 512 |
| Long-term debt | 2 326 | 2 561 | 2 454 | 2 656 | 2 366 | 2 324 | 2 461 |
| Short-term debt | 190 | 358 | 424 | 152 | 1 450 | 1 009 | 1 450 |
| Total debt | 2 516 | 2 918 | 2 877 | 2 807 | 3 815 | 3 332 | 3 911 |
EBITDA margin
-73793800.0%
This company
15.8%
Market median
-467049467% vs market
20182024
Equity ratio
-880.2%
This company
38.2%
Market median
-2404% vs market
20182024
Return on equity
-95025700.0%
This company
18.4%
Market median
-516444122% vs market
20182024
Net profit margin
-95025700.0%
This company
8.1%
Market median
-1173156890% vs market
20182024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20182024
Debt / equity
1.11×
This company
0.62×
Market median
-79% vs market
20182024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via PRH / YTJ · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AP Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
JA | Audit | 2010 | — | — |
PM Audit | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairperson | 2017 | — | — | |
| Board of Directors | 2017 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Aplagon Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Aki Pellervo Prihti | Chief Executive Officer | 0 companies |
| Janne Antero Rajalahti | Audit | 0 companies |
| Paula Maria Roima | Audit | 0 companies |
| Kai Harald Eugen Lindevall | Board of Directors | 0 companies |
| Harry Ben Holthöfer | Board of Directors | 0 companies |
| Joanne Patra Pisani | Board of Directors | 0 companies |
| Johanna Kristina Asklin | Board of Directors | 0 companies |
| Yrjö Sakari Lassila | Chairperson | 0 companies |
| Steven Hla Myint | Board of Directors | 0 companies |